FUP-COVID: Follow-up of Critical COVID-19 Patients
Study Details
Study Description
Brief Summary
The study will follow COVID-19 patients who required intensive care after 3-6 months and one year after discharge from the ICU with functional level as well as organ function to assess recovery after COVID-19. Blood and urine will be collected for biobanking.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The study will follow COVID-19 patients who required intensive care at Uppsala University Hospital and were included in the Uppsala COVID-19 biobank. The patients will be contacted after three to six months for a first follow-up with assessment of functional level in activities of daily life, psychiatric symptoms, neurological symptoms and working capacity as well as specific organ functions. The organ functions will include circulation, respiration, coagulation, immune function and kidney function. In addition, blood and urine will be collected for biobanking.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
COVID-19 Patients with PCR-confirmed COVID-19 who were treated in the intensive care unit. |
Outcome Measures
Primary Outcome Measures
- Mortality [Within 90 days after admission to ICU.]
Death
- Mortality [Within 1 year after admission to ICU.]
Death
- Renal recovery [At follow-up three to six months after ICU discharge.]
Return of renal function measured as CKD stage.
- Renal recovery [At follow-up one year after ICU discharge.]
Return of renal function measured as CKD stage.
- Respiratory recovery [Three to six months from discharge from ICU]
Respiratory function as assessed by a clinician
- Working capacity [Three to six months from discharge from ICU]
6 min walk test
- Quality of life score [Three to six months from discharge from ICU]
Quality of Life assessed using the 36-item short form survey by RAND.
- Cognitive recovery [Three to six months from discharge from ICU]
Cognitive screening using the Montreal Cognitive Assessment.
- Frailty [Three to six months from discharge from ICU]
Screening for frailty using the Clinical Frailty Scale-9.
- Activities of Daily Life [Three to six months from discharge from ICU]
Screening of functional level for Activities of Daily Life using the 5-level EQ-5D.
- Anxiety [Three to six months from discharge from ICU]
Screening for anxiety using the Generalised Anxiety Disorder 7-item scale.
- Depression [Three to six months from discharge from ICU]
Screening for depression using the Patient Health Questionnaire 9.
- Neurological recovery [Three to six months from discharge from ICU]
Neurological function as assessed by a clinician
Eligibility Criteria
Criteria
Inclusion Criteria:
-
PCR-verified Covid-19
-
Treated in ICU
Exclusion Criteria:
- Pregnant of breastfeeding
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Uppsala University Hospital | Uppsala | Sweden | 75185 |
Sponsors and Collaborators
- Uppsala University
- Uppsala University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EPM-2020-02697